On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis

Discrete and Continuous Dynamical Systems - Series B

Volumn 11, Issue 3, 2009, Pages 691-715

  Ledzewicz, Urszula ^a   Schättler, Heinz ^b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Anti angiogenesis; Cancer treatment; Lie bracket; Maximum principle; Optimal control; Regular synthesis; Singular control

Indexed keywords

EID: 67650860391     PISSN: 15313492     EISSN: None     Source Type: Journal    
DOI: 10.3934/dcdsb.2009.11.691     Document Type: Article

References (36)

1. Z. Agur, L. Arakelyan, P. Daugulis and Y. Ginosar, Hopf point analysis for angiogenesis models, Discrete and Continuous Dynamical Systems, Series B, 4 (2004), 29-38.
2. A. Anderson and M. Chaplain, Continuous and discrete mathematical models of tumorinduced angiogenesis, Bull. Math. Biol., 60 (1998), 857ff.
3. B. Bonnard and M. Chyba, "Singular Trajectories and their Role in Control Theory," Springer Verlag, Series: Mathematics and Applications, Vol.40, 2003.
4. A. Bressan and B. Piccoli, "Introduction to the Mathematical Theory of Control," American Institute of Mathematical Sciences, 2007.
5. A. E. Bryson and Y. C. Ho, "Applied Optimal Control," Hemisphere Publishing, 1975.
6. F. Castiglione and B. Piccoli, Optimal control in a model of dendritic cell transfection cancer immunotherapy, Bulletin of Mathematical Biology, 68 (2006), 255-274.
7. L. G. de Pillis and A. Radunskaya, .A mathematical tumor model with immune resistance and drug therapy: An optimal control approach, J. of Theoretical Medicine, 3 (2001), 79-100
8. A. d'Onofrio, A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences, Physica D, 208 (2005), 220-235.
9. A. d'Onofrio and A. Gandolfi, Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999), Math. Biosci., 191 (2004), 159-184
10. M. Eisen, "Mathematical Models in Cell Biology and Cancer Chemotherapy," Lecture Notes in Biomathematics, Vol.30, Springer Verlag, 1979.
11. A. Ergun, K. Camphausen and L. M. Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors, Bull. of Math. Biology, 65 (2003), 407-424
12. K. R. Fister and J. C. Panetta, Optimal control applied to cell-cycle-specific cancer chemotherapy, SIAM J. Appl. Math., 60 (2000), 1059-1072.
13. U. Forys, Y. Keifetz and Y. Kogan, Critical-point analysis for three-variable cancer angiogenesis models, Mathematical Biosciences and Engineering, 2 (2005), 511-525.
14. H. Gardner-Moyer, Sufficient conditions for a strong minimum in singular control problems, SIAM J. Control, 11 (1973), 620-636.
15. P. Hahnfeldt, D. Panigrahy, J. Folkman and L. Hlatky, Tumor development under angiogenic signaling: A dynamical theory of tumor growth, treatment response, and postvascular dormancy, Cancer Research, 59 (1999), 4770-4775.
16. R. S. Kerbel, A cancer therapy resistant to resistance, Nature, 390 (1997), 335-336.
17. A. Krener, The high-order maximal principle and its application to singular controls, SIAM J. Control and Optimization, 15 (1977), 256-293.
18. U. Ledzewicz and H. Schättler, Optimal bang-bang controls for a S-compartment model in cancer chemotherapy, J. of Optimization Theory and Applications - JOTA, 114 (2002), 609-637.
19. U. Ledzewicz and H. Schättler, A synthesis of optimal controls for a model of tumor growth under angiogenic inhibitors, Proceedings of the 44th IEEE Conference on Decision and Control (CDC) and European Control Conference ECC'05, Sevilla, Spain, December 2005, 934-939
20. U. Ledzewicz and H. Schättler, Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy, Mathematical Biosciences, 206 (2007), 320-342.
21. U. Ledzewicz and H. Schättler, On a class of systems describing tumor anti-angiogenesis under Gompertzian growth, WSEAS Transactions on Systems, 4 (2007), 758-766
22. U. Ledzewicz and H. Schättler, Anti-angiogenic therapy in cancer treatment as an optimal control problem, SIAM J. on Control and Optimization, 46 (2007), 1052-1079.
23. U. Ledzewicz and H. Schattier, Analysis of a mathematical model for tumor anti-angiogenesis, Optimal Control Appl. and Methods, 29 (2008), 41-57.
24. U. Ledzewicz and H. Schättler, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis, J. of Theoretical Biology, 252 (2008), 295-312.
25. U. Ledzewicz and H. Schättler, Minimization of the tumor volume and endothelial support for a system describing tumor anti-angiogenesis, WSEAS Transactions on Biology and Biomedicine, 5 (2008), 23-33
26. H. Maurer, G. Büskens, J.-H. Kim and Y. Kaja, Optimization techniques for the verification of second-order sufficient conditions for bang-bang controls, Optimal Control, Applications and Methods, 26 (2005), 129-156.
27. L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze and E. F. Mishchenko, "The Mathematical Theory of Optimal Processes," MacMillan, New York, 1964.
28. R. K. Sachs, L. R. Hlatky and P. Hahnfeldt, Simple ODE models of tumor growth and antiangiogenic or radiation treatment, Math. Comput. Mod., 33 (2001), 1297-1305.
29. G. Stefani, On sufficient optimality conditions for singular extremals, Proceedings of the 42nd IEEE Conference on Decision and Control (CDC), Maui, Hi, USA, December 2003, 2746-2749.
30. G. W. Swan, Role of optimal control in cancer chemotherapy, Math. Biosci., 101 (1990), 237-284.
31. A. Swierniak, Optimal treatment protocols in leukemia - modelling the proliferation cycle, Proceedings of the 12th IMACS World Congress, Paris, 4 (1988), 170-172.
32. A. Swierniak, Cell cycle as an object of control, J. of Biological Systems, 3 (1995), 41-54.
33. A. Swierniak, U. Ledzewicz and H. Schattier, Optimal control for a class of compartmental models in cancer chemotherapy, Int. J. Applied Mathematics and Computer Science, 13 (2003), 357-368.
34. A. Swierniak, A. Polanski and M. Kimmel, Optimal control problems arising in cell-cycle-specific cancer chemotherapy, Cell prolif., 29 (1996), 117-139.
35. A. Swierniak, G. Gala, A. Gandolfi and A. d'Onofrio, Optimization of angiogenic therapy as optimal control problem, Proceedings of the 4th IASTED Conference on Biomechanics, Acta Press, (Ed. M. Doblare), (2006), 56-60.
36. A. Swierniak, Direct and indirect control of cancer populations, Bulletin of the Polish Academy of Sciences, Technical Sciences, 56, (2008), 367-378.